Guidelines--for the obedience of fools and the guidance of wise men?

@article{Hampton2003GuidelinesforTO,
  title={Guidelines--for the obedience of fools and the guidance of wise men?},
  author={John R. Hampton},
  journal={Clinical medicine},
  year={2003},
  volume={3 3},
  pages={
          279-84
        }
}
  • J. Hampton
  • Published 1 May 2003
  • Medicine
  • Clinical medicine
Guidelines for medical management are now part of medical life. A fool--loosely defined as someone who does not know much about a particular area of medicine--will do well to follow guidelines when treating patients, but a wise man (again, loosely defined as someone who does know about the disease in question) might do better not to follow them slavishly. The problem is that the evidence on which guidelines are based is seldom very good. Clinical trials have a variety of problems which often… 

How does evidence based guidance influence determinations of medical negligence?

  • B. Hurwitz
  • Medicine
    BMJ : British Medical Journal
  • 2004
The legal status of evidence based guidance is examined, including whether guidelines from the National Institute for Clinical Excellence (NICE) should be understood to carry special importance in helping courts to decide whether or not allegations of negligence should be upheld.

Bin it or pin it? Which professional ethical guidance on managing COVID-19 should I follow?

Adopting a working definition of “professional ethical guidance”, this work offers three domains for a healthcare professional to consider, and some associated questions to ask, when determining whether – in relation to any guidance document – they should “bin it or pin it”.

Achieving high-quality care: a view from NICE

The research evidence is clear that a change in practice rarely comes about as a result of simply disseminating guidance on best practice, so a systematic process for putting change in place should include identifying barriers to change, agreeing interventions to overcome the barriers and drive forward improvement.

Nursing interventions for preventing alcohol-related harm.

The current evidence-based guidelines in this area are introduced and the 'consensus model' contained within them are used to describe the process of effective alcohol intervention.

Evidence-based practice: a trainee clinical psychologist perspective

The findings suggest that the SPM may be more accurately termed the reflective-scientist-practitioner, or the critical-reflective-scientists- Practitioner; in acknowledgment of the importance placed on these skills by participants who saw them as central to their role.

AGREEing on Canadian cardiovascular clinical practice guidelines.

Lessons from the vaginal mesh scandal: enhancing the patient-centric approach to informed consent for medical device implantation

  • J. O'Neill
  • Medicine
    International Journal of Technology Assessment in Health Care
  • 2021
Recommendations are made that conflict of interest disclosure be mandated, greater value be afforded to patient-based evidence to improve evaluation of treatments, and that information disclosure for informed consent should relate to the risks, benefits, and alternatives to the surgical procedure and medical device.

Screening and treatment for prostate cancer: The evidence and implications for practice

The options for management and treatment are discussed in the light of NICE recommendations and the relative merits of each are considered.

References

SHOWING 1-10 OF 19 REFERENCES

Evidence based medicine: what it is and what it isn't

As evidence based medicine continues to evolve and adapt, now is a useful time to refine the discussion of what it is andWhat it is not.

National service framework for coronary heart disease

The common practice of starting treatment before discharge is not strictly evidence based and statin treatment may be harmful immediately after myocardial infarction, so the results of comparative audit will be meaningless.

Discrepancies between meta-analyses and subsequent large randomized, controlled trials.

The outcomes of the 12 large randomized, controlled trials that were studied were not predicted accurately 35 percent of the time by the meta-analyses published previously on the same topics.

The effect of digoxin on mortality and morbidity in patients with heart failure.

Digoxin did not reduce overall mortality, but it reduced the rate of hospitalization both overall and for worsening heart failure, which defines more precisely the role of digoxin in the management of chronic heart failure.

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

There was no appreciable evidence that either a higher aspirin dose or any other antiplatelet regimen was more effective than medium dose aspirin in preventing vascular events, so in each of the four main high risk categories overall mortality was significantly reduced.

Trial of early nifedipine in acute myocardial infarction: the Trent study.

Subgroup analysis also did not suggest any particular group of patients with suspected acute myocardial infarction who might benefit from early nifedipine treatment in the dose studied.

Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis

Patients deemed ineligible for thrombolysis are high risk, receive less surveillance, are less likely to be revascularised or receive trial proven treatments, have a poor long term outcome not entirely explained by increased age or severity of infarction, and deserve further evaluation.

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Long-term treatment with trandolapril in patients with reduced left ventricular function soon after myocardial infarction significantly reduced the risk of overall mortality, mortality from cardiovascular causes, sudden death, and the development of severe heart failure.